Literature DB >> 8103915

Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.

J Blasi1, E R Chapman, E Link, T Binz, S Yamasaki, P De Camilli, T C Südhof, H Niemann, R Jahn.   

Abstract

Neurotransmitter release is potently blocked by a group of structurally related toxin proteins produced by Clostridium botulinum. Botulinum neurotoxin type B (BoNT/B) and tetanus toxin (TeTx) are zinc-dependent proteases that specifically cleave synaptobrevin (VAMP), a membrane protein of synaptic vesicles. Here we report that inhibition of transmitter release from synaptosomes caused by botulinum neurotoxin A (BoNT/A) is associated with the selective proteolysis of the synaptic protein SNAP-25. Furthermore, isolated or recombinant L chain of BoNT/A cleaves SNAP-25 in vitro. Cleavage occurred near the carboxyterminus and was sensitive to divalent cation chelators. In addition, a glutamate residue in the BoNT/A L chain, presumably required to stabilize a water molecule in the zinc-containing catalytic centre, was required for proteolytic activity. These findings demonstrate that BoNT/A acts as a zinc-dependent protease that selectively cleaves SNAP-25. Thus, a second component of the putative fusion complex mediating synaptic vesicle exocytosis is targeted by a clostridial neurotoxin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103915     DOI: 10.1038/365160a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  293 in total

1.  Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.

Authors:  M Wictome; K Newton; K Jameson; B Hallis; P Dunnigan; E Mackay; S Clarke; R Taylor; J Gaze; K Foster; C Shone
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

2.  Syntaxin modulation of calcium channels in cortical synaptosomes as revealed by botulinum toxin C1.

Authors:  J B Bergsman; R W Tsien
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

3.  High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.

Authors:  D D Pless; E R Torres; E K Reinke; S Bavari
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  alpha-latrotoxin triggers transmitter release via direct insertion into the presynaptic plasma membrane.

Authors:  M Khvotchev; T C Südhof
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 5.  [Use of botulinum toxin the the treatment of muscle pain].

Authors:  R Benecke; D Dressler; E Kunesch; T Probst
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

6.  Developmental and functional nature of human iPSC derived motoneurons.

Authors:  Marianne Stockmann; Leonhard Linta; Karl J Föhr; Anja Boeckers; Albert C Ludolph; Georges F Kuh; Patrick T Udvardi; Christian Proepper; Alexander Storch; Alexander Kleger; Stefan Liebau; Tobias M Boeckers
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

Review 7.  Synaptic vesicle exocytosis.

Authors:  Thomas C Südhof; Josep Rizo
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-12-01       Impact factor: 10.005

8.  Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development.

Authors:  I C Bark; K M Hahn; A E Ryabinin; M C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.

Authors:  Paul L Durham; Caleb G Masterson
Journal:  Headache       Date:  2012-10-23       Impact factor: 5.887

10.  Vam7p, a SNAP-25-like molecule, and Vam3p, a syntaxin homolog, function together in yeast vacuolar protein trafficking.

Authors:  T K Sato; T Darsow; S D Emr
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.